Live Chat
Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Applied Clear All

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Article
    Rasheev H, Stoyanova R, Tadjer A.
    ACS Omega. 2021 Nov 09;6(44):29735-29745.
    Spinel lithium titanate, Li4Ti5O12 (LTO), emerges as a "universal" electrode material for Li-ion batteries and hybrid Li/Na-, Li/Mg-, and Na/Mg-ion batteries functioning on the basis of intercalation. Given that LTO operates in a variety of electrolyte solutions, the main challenge is to understand the reactivity of the LTO surface toward single- and dual-cation electrolytes at the molecular level. This study first reports results on ion desolvation and electrolyte solvent/salt degradation on an LTO surface by means of periodic DFT calculations. The desolvation stages are modeled by the adsorption of mono- and binuclear complexes of Li+, Na+, and Mg2+ with a limited number of ethylene carbonate (EC) solvent molecules on the oxygen-terminated LTO (111) surface, taking into account the presence of a PF6 - counterion. Alongside cation adsorption, several degradation reactions are discussed: surface-catalyzed dehydrogenation of EC molecules, simultaneous dehydrogenation and fluorination of EC, and Mg2+-induced decay of PF6 - to PF5 and F-. Data analysis allows the rationalization of existing experimentally established phenomena such as gassing and fluoride deposition. Among the three investigated cations, Mg2+ is adsorbed most tightly and is predicted to form a thicker fluoride-containing film on the LTO surface. Gassing, characteristic for carbonate-based electrolytes with LTO electrodes, is foreseen to be suppressed in dual-cation batteries. The latter bears promise to outperform the single-ion ones in terms of durability and safety.
    Digital Access Access Options
  • Article
    Cui T, Xiao X, Pan Z, Tang K, Zhong Y, Chen Y, Guo J, Duan S, Zhong G, Li T, Li X, Wu X, Lin C, Yang X, Gao Y, Zhang D.
    ACS Omega. 2023 Aug 15;8(32):29735-29745.
    Nonalcoholic fatty liver disease (NAFLD) is a prevalent global condition and a common precursor to liver cancer, yet there is currently no specific medication available for its treatment. Ginseng, renowned for its medicinal and dietary properties, has been utilized in NAFLD management, although the precise underlying mechanism remains elusive. To investigate the effectiveness of ginsenoside Rd, we employed mouse and cell models to induce NAFLD using high-fat diets, oleic acid, and palmitic acid. We explored and confirmed the specific mechanism of ginsenoside Rd-induced hepatic steatosis through experiments involving mice with a liver-specific knockout of SIRT6, a crucial protein involved in metabolic regulation. Our findings revealed that administration of ginsenoside Rd significantly reduced the inflammatory response, reactive oxygen species (ROS) levels, lipid peroxide levels, and mitochondrial stress induced by oleic acid and palmitic acid in primary hepatocytes, thereby mitigating excessive lipid accumulation. Moreover, ginsenoside Rd administration effectively enhanced the mRNA content of key proteins involved in fatty acid oxidation, with a particular emphasis on SIRT6 and its target proteins. We further validated that ginsenoside Rd directly binds to SIRT6, augmenting its deacetylase activity. Notably, we made a significant observation that the protective effect of ginsenoside Rd against hepatic disorders induced by a fatty diet was almost entirely reversed in mice with a liver-specific SIRT6 knockout. Our findings highlight the potential therapeutic impact of Ginsenoside Rd in NAFLD treatment by activating SIRT6. These results warrant further investigation into the development of Ginsenoside Rd as a promising agent for managing this prevalent liver disease.
    Digital Access Access Options
  • Article
    Summart R, Thaichana P, Supan J, Meepowpan P, Lee TR, Tuntiwechapikul W.
    ACS Omega. 2020 Nov 24;5(46):29733-29745.
    Perylene diimide (PDI) derivatives have been studied as G-quadruplex ligands that suppress telomerase activity by facilitating G-quadruplex formation of telomeric DNA and the hTERT promoter. PIPER, the prototypical PDI, reduces telomerase activity in lung and prostate cancer cells, leading to telomere shortening and cellular senescence of these cells. However, PIPER suffers from poor hydrosolubility and the propensity to aggregate at neutral pH. In this report, we synthesized a new asymmetric PDI, aPDI-PHis, which maintains one N-ethyl piperidine side chain of PIPER and has histidine as another side chain. The results show that aPDI-PHis is superior to its symmetric counterparts, PIPER and PDI-His, in terms of hydrosolubility, G-quadruplex binding, cellular uptake, and telomerase inhibition in prostate cancer cells. These results suggest that one N-ethyl piperidine side chain of PDI is sufficient for G-quadruplex binding, while another side chain can be tuned to elicit desirable properties. These findings might lead to better PDIs for use as anticancer drugs.
    Digital Access Access Options